Abu Dhabi and Children's Hospital of Philadelphia Join Forces to Enhance Gene Editing for Rare Diseases

A Breakthrough Collaboration in Gene Editing

The healthcare landscape is witnessing a pivotal moment as the Department of Health – Abu Dhabi (DoH) partners with the renowned Children's Hospital of Philadelphia (CHOP) to push the boundaries of gene editing technology, particularly for rare diseases. Announced during the BIO International Convention in San Diego, this collaboration aims to leverage CHOP's unparalleled expertise in gene therapy and Abu Dhabi's ambitious genomic capabilities to transform the future of precision medicine.

Key Elements of the Strategic Alliance

The foundation of this strategic collaboration lies in a Memorandum of Understanding (MoU) signed by key representatives from both institutions. Through this agreement, CHOP will provide specialized training to local clinician-scientists in Abu Dhabi, focusing on innovative techniques in gene editing aimed at tackling various rare diseases that affect children. The objective is to enhance local expertise while honing specialized skills in therapies, such as base-editing approaches targeting liver metabolic disorders, genetic clotting disorders, urea cycle disorders, and central nervous system conditions.

H.E. Dr Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, emphasized, "Abu Dhabi has built one of the world's most advanced intelligent health systems. With nearly one million genomes sequenced through the Emirati Genome Program, we have the foundation to translate genomic insights into life-changing treatments at a population scale. Our partnership with Children's Hospital of Philadelphia will strengthen local capabilities and train the next generation of clinician-scientists, ensuring that advanced therapies become accessible to children living with rare genetic diseases in our region."

Significance of the Emirati Genome Program

Abu Dhabi's comprehensive genomics ecosystem, underscored by initiatives like the Emirati Genome Program, plays a crucial role in addressing the healthcare challenges posed by genetic conditions. The program is designed to facilitate the early identification of inherited diseases, ultimately creating a reservoir of genomic insights that inform more precise therapeutic interventions. Such initiatives are indispensable in developing advanced therapies tailored to the unique healthcare needs of the region's population.

CHOP’s Role in the Collaboration

CHOP stands at the forefront of advancing personalized gene editing, particularly in liver-directed therapies. This approach demonstrates the potential to correct single DNA letters in the liver to treat hundreds of inherited conditions, revolutionizing the prospects for many children affected by these diseases. The hospital has made significant strides in this area by rapidly creating the first personalized gene-editing therapy for a baby with a rare metabolic disease, showcasing that targeted gene fixes can be safe and quickly developed.

Beverly L. Davidson, PhD, Director of the Raymond G. Perelman Center for Cellular and Molecular Therapeutics at CHOP, stated, "Our program will equip Abu Dhabi researchers with hands-on experience, guiding them through the process of translating laboratory discoveries into effective therapies. From trial design to patient care, our collaboration aims to set a new standard in the field of gene therapy."

Future Prospects

The partnership encompasses a broad spectrum of activities across the gene-editing value chain, which includes scientific research, clinical translation, talent development, and future therapeutic applications. Abu Dhabi is creating a conducive environment for such scientific advances through initiatives like the Health, Endurance, Longevity, and Medicine (HELM) cluster, fostering an ecosystem where discovery, validation, and implementation can thrive cohesively.

In conclusion, the collaboration between the Department of Health – Abu Dhabi and the Children's Hospital of Philadelphia marks a forward-thinking approach to healthcare, focusing on the crucial intersection of gene editing technology and rare disease treatment. With both entities committed to nurturing local talent and developing innovative therapies, patients in Abu Dhabi and beyond can look forward to a future where cutting-edge medical advancements become a reality.

About the Department of Health – Abu Dhabi

As the regulator of the healthcare sector in the Emirates, the Department of Health in Abu Dhabi works diligently to ensure healthcare excellence. By monitoring health trends and establishing a regulatory framework, DoH upholds world-class standards for healthcare providers across the region.

About the Children's Hospital of Philadelphia

Founded in 1855, CHOP has distinguished itself as the first pediatric hospital in the United States, consistently providing advanced medical care and conducting groundbreaking research for the benefit of children worldwide. Its collaborative model encompasses a wide range of healthcare services, ensuring that pediatric needs are met effectively and comprehensively.